Next-Generation Onco-Therapeutics

Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. Dr. Banashree Bondhopadhyay is an Assistant Professor at the Centre for Medical Biotechnology, Amity University Uttar Pradesh, Noida, India. She earned her PhD from the University of Burdwan and completed her post-doctoral fellowship at ICMR-NICPR. Her research focuses on molecular oncology, with particular emphasis on breast cancer and hybrid anti-cancer natural products, and her work has appeared in journals including Biosensors and Bioelectronics and Cancers. She has over 17 SCI-indexed publications and is a recipient of the ICMR-DHR Women Scientist Fellowship and the Shri K.N. Narasimhiah Award.

• CHAPTER 1 Introduction to next-generation oncotherapeutics and evolution of cancer therapyCHAPTER 2 Transforming cancer treatment through immunotherapy innovationsCHAPTER 3 Immune checkpoint inhibitors: mechanisms, efficacy, and challengesCHAPTER 4 Targeted therapy advancements in tumor biologyCHAPTER 5 Psychosocial support and dietary regulations in cancer careCHAPTER 6 Engineering microbes for cancer: advances in oncolytic microbial therapyCHAPTER 7 Precision medicine in oncology treatmentsCHAPTER 8 Gene engineering and editing in cancer therapeuticsCHAPTER 9 Integrative therapies and combination approaches for synergistic cancer therapeuticsCHAPTER 10 The importance of early detection and screening in cancer treatmentCHAPTER 11 Patient-centered care for cancer therapeuticsCHAPTER 12 Advances in cancer drug discovery integrated with computational approachesCHAPTER 13 Technological advances in oncotherapeuticsCHAPTER 14 Ethics and accessibility in next generation cancer therapiesCHAPTER 15 Case studies and future prospects of next-generation onco-therapeutics